Home / Companies / Iview Therapeutics Inc / Trends
Iview Therapeutics Inc H-1B trends
Quarterly LCA aggregate trend points for Iview Therapeutics Inc. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.
Summary
H-1B LCA filings for Iview Therapeutics Inc span 2017 Q2 to 2025 Q2, peaking at 3 filings in 2022 Q3.
The most recent reported period (2025 Q2) shows 2 filings.
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Period | LCA count | Role titles | SOC codes | Avg wage low | Avg prevailing | Certified | Certification rate |
|---|---|---|---|---|---|---|---|
| 2017 Q2 | 1 | 1 | 1 | $54,000 | $53,726 | 1 | 100.0% |
| 2022 Q2 | 1 | 1 | 1 | $90,179 | $86,923 | 1 | 100.0% |
| 2022 Q3 | 3 | 1 | 2 | $100,000 | $86,507 | 3 | 100.0% |
| 2025 Q2 | 2 | 1 | 1 | $103,500 | $103,334 | 2 | 100.0% |
Frequently asked questions
- How have H-1B filings for Iview Therapeutics Inc changed over time?
- H-1B LCA filings for Iview Therapeutics Inc span 2017 Q2 to 2025 Q2, peaking at 3 filings in 2022 Q3. The most recent reported period (2025 Q2) shows 2 filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=iview+therapeutics+inc&metric=lca_countJSON